Marc Forth - Mar 19, 2024 Form 4 Insider Report for AEON Biopharma, Inc. (AEON)

Role
CHIEF EXECTUIVE OFFICER, Director
Signature
/s/ Alexander Wilson as attorney-in-fact for Marc Forth
Stock symbol
AEON
Transactions as of
Mar 19, 2024
Transactions value $
$0
Form type
4
Date filed
3/21/2024, 07:49 PM
Previous filing
Jul 24, 2023
Next filing
Sep 4, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AEON Stock Option Award $0 +212K $0.00 212K Mar 19, 2024 Common Stock 212K $14.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of stock options granted on March 19, 2024 (the "Grant Date"), which vests in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to the reporting person's continued service through the applicable vesting date.